Program Type
Disease
Project Status

Displaying 76 - 97 of 97

Adam J. Berry Memorial Fund
Overview Since 2003, the Adam J. Berry Memorial Fund has supported travel  for early-career Australian scientists to work at the NIH, in p...
ACTIV Seminar Series: Post-Acute Sequelae of SARS-CoV-2
Overview COVID patients who experience lingering symptoms for months or weeks after initial recovery are said to have post-acute sequelae o...
Accelerating Medicines Partnership® Program – Rheumatoid Arthritis, Systemic Lupus Erythematosus
The Problem Autoimmune disorders such as Rheumatoid Arthritis and Systemic Lupus Erythematosus are biologically complex; understanding the ...
The Deeda Blair Research Initiative for Disorders of the Brain 
The Deeda Blair Research Initiative was created to improve the diagnosis and treatment of severe mental illness, including mood disorders, a...
Charles A. Sanders, MD Partnership Award
In honor of its former Chairman of the Board, the FNIH celebrates its partners through the Charles A. Sanders, MD, Partnership Award. The aw...
Trailblazer Prize for Clinician-Scientists
The Trailblazer Prize for Clinician-Scientists (Trailblazer Prize) recognizes the outstanding contributions of early career clinician-scient...
AMP Common Metabolic Disorders
The Accelerating Medicines Partnership® (AMP®) Program in Common Metabolic Diseases (AMP CMD) is a collaborative partnership among governm...
AMP Autoimmune & Immune-Mediated Diseases
The Accelerating Medicines Partnership® (AMP®) Program Autoimmune and Immune-Mediated Diseases (AMP AIM) is a precompetitive partnership t...
AMP Alzheimer’s Disease 1.0
The Accelerating Medicines Partnership® (AMP®) Program Alzheimer’s disease (AMP AD) was the first stage of a precompetitive partnership ...
AMP Schizophrenia 
The Accelerating Medicines Partnership® (AMP®) Program Schizophrenia (AMP SCZ) is the first neuropsychiatric project of the landmark AMP p...
AMP Parkinson’s Disease
The Accelerating Medicines Partnership® (AMP®) Program Parkinson’s disease (AMP PD) is a public-private partnership among NIH and privat...
AMP Heart Failure
The Accelerating Medicines Partnership® Heart Failure program (AMP® HF) is focused on a major unmet need in cardiovascular health. AMP HF ...
AMP Alzheimer’s Disease 2.0
The Accelerating Medicines Partnership® (AMP®) Program Alzheimer’s disease (AMP AD 2.0) is a precompetitive public-private partnership t...
AMP® Bespoke Gene Therapy Consortium (BGTC)
The Accelerating Medicines Partnership® (AMP®) Program Bespoke Gene Therapy Consortium (AMP BGTC) brings together partners from the public...
Accelerating Medicines Partnership® (AMP®)
Our mission is to improve understanding of disease pathways, facilitate better selection of targets for treatment and identify platforms and...

Diseases

Partner With Us